# Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma

> clinical trial · VERIFIED · 2026-08-12

Status: RECRUITING · Sponsor: Giselle Sholler · Condition: Neuroblastoma

- Company: Giselle Sholler
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT05489887

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.